恶性横纹肌样瘤及相关儿童肿瘤:多模态影像学综述与病理对照
恶性横纹肌样瘤(MRT)是罕见但致死性的实体肿瘤,主要累及婴幼儿,好发于中枢神经系统、肾脏和软组织,部位决定命名。SMARCB1(罕见SMARCA4)的体细胞和生殖细胞突变是其基础。US、CT、MRI和FDG PET/CT或PET/MRI有助于诊断、分期和随访。多灶同步或异时性肿瘤多见于横纹肌样瘤易感综合征(RTPS),RTPS的影像监测指南基于诊断时年龄。
要点
- MRT的诊断需结合发病部位、影像特征及SMARCB1/SMARCA4基因检测。
- 多灶同步或异时性MRT应警惕RTPS,需基因检测和遗传咨询。
- RTPS的影像监测指南基于诊断时年龄制定。
核心结论
- MRT是罕见致死性肿瘤,影像学表现与常见实体瘤有重叠,但存在部位特异性特征;诊断、分期和随访依赖多模态影像,并需结合SMARCB1/SMARCA4遗传学检测。
研究设计与样本
- 综述:总结MRT及相关儿童肿瘤的多模态影像学表现与病理相关性,并讨论RTPS的影像监测指南。
关键影像表现/征象
- 中枢神经系统是MRT最常见发生部位,肿瘤也可发生于肾脏和全身软组织。
- MRT的临床和影像表现可与更常见实体瘤重叠,但存在一些部位特异性影像特征。
临床应用与阅片要点
- US、CT、MRI和FDG PET/CT或PET/MRI有助于MRT的诊断、初始分期和随访,从而为治疗决策提供信息。
- 多灶同步或异时性横纹肌样瘤主要见于RTPS背景,需进行基因检测和遗传咨询。
- RTPS的影像监测指南基于诊断时年龄制定。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Malignant rhabdoid tumors (MRTs) are rare but lethal solid neoplasms that overwhelmingly affect infants and young children. While the central nervous system is the most common site of occurrence, tumors can develop at other sites, including the kidneys and soft tissues throughout the body. The anatomic site of involvement dictates tumor nomenclature and nosology. While the clinical and imaging manifestations of MRTs and other more common entities may overlap, there are some site-specific distinctive imaging characteristics. Irrespective of the site of occurrence, somatic and germline mutations in SMARCB1, and rarely in SMARCA4, underlie the entire spectrum of rhabdoid tumors. MRTs have a simple and remarkably stable genome but can demonstrate considerable molecular and biologic heterogeneity. Related neoplasms encompass an expanding category of phenotypically dissimilar (nonrhabdoid tumors driven by SMARC-related alterations) entities. US, CT, MRI, and fluorodeoxyglucose PET/CT or PET/MRI facilitate diagnosis, initial staging, and follow-up, thus informing therapeutic decision making. Multifocal synchronous or metachronous rhabdoid tumors occur predominantly in the context of underlying rhabdoid tumor predisposition syndromes (RTPSs). These autosomal dominant disorders are driven in most cases by pathogenic variants in SMARCB1 (RTPS type 1) and rarely by pathogenic variants in SMARCA4 (RTPS type 2). Genetic testing and counseling are imperative in RTPS. Guidelines for imaging surveillance in cases of RTPS are based on age at diagnosis. ©RSNA, 2024 Supplemental material is available for this article.
引用
- Lorca MC, Huang J, Schafernak K, et al. Malignant Rhabdoid Tumor and Related Pediatric Tumors: Multimodality Imaging Review with Pathologic Correlation. Radiographics. 2024. PMID: 39088359. doi:10.1148/rg.240015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。